Breaking News Instant updates and real-time market news.

AMRS

Amyris

$3.88

0.05 (1.31%)

17:31
03/19/19
03/19
17:31
03/19/19
17:31

Amyris to delay filing 10-K, may have further financial reporting deficiences

Amyris was unable to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2018 within the prescribed time period without unreasonable effort and expense because of the significant time and resources that were devoted to the accounting for and disclosure of the significant transactions with Koninklijke DSM N.V. that closed in November 2018. The company is also in the process of completing its evaluation of internal control over financial reporting for 2018 and finalizing related disclosures in the Form 10-K. These activities delayed the completion of the Form 10-K. As previously reported in Part II, Item 9A, "Controls and Procedures" of the company's Annual Report on Form 10-K for the fiscal year ended December 31, 2017, the company has identified a material weakness in its internal control over financial reporting, which material weakness remains unremediated as of December 31, 2018. The company is in the process of completing its evaluation of internal control over financial reporting and may have further deficiencies to report. In addition, the company expects to continue to report that there is substantial doubt about its ability to continue as a going concern.

AMRS Amyris
$3.88

0.05 (1.31%)

11/14/18
HCWC
11/14/18
NO CHANGE
Target $11
HCWC
Buy
Amyris price target lowered to $11 from $15 at H.C. Wainwright
H.C. Wainwright analyst Amit Dayal lowered his price target for Amyris to $11 to reflect a more conservative stance on forward projections, including removing around $40M of anticipated annual Vitamin E royalty revenues, following the company's revenue miss in Q3. The analyst, however, keeps a Buy rating on the shares.
12/07/18
HCWC
12/07/18
NO CHANGE
HCWC
Amyris financing removes 'important overhang,' says H.C. Wainwright
H.C. Wainwright analyst Amit Dayal reiterated a Buy rating and $11 price target on Amyris, noting that the company announced it has entered into definitive agreements for the sale of $60M of unsecured convertible senior notes, in a private placement with two investors. Dayal said this financing removes an "important overhang" for the company, and believes that Amyris is now positioned to focus on execution during 2019. The analyst added that he is looking forward to more information from the company during the last three weeks of this year, including the announcement of a Chinese licensing agreement.
12/31/18
HCWC
12/31/18
NO CHANGE
Target $11
HCWC
Buy
Amyris news today a 'significant near-term milestone,' says H.C. Wainwright
H.C. Wainwright analyst Amit Dayal maintains a Buy rating on Amyris with an $11 price target after the company entered into a long-term agreement with Xinfu for an upfront payment of $50M and an additional long-term annual share upside based on an existing nutritional product royalty arrangement. Amyris is capitalizing on its relationship with Xinfu to monetize a portion of the long-term royalty opportunity upfront, which should lower quarterly volatility from this "high-margin" revenue stream while continuing to benefit from future royalty payments, Dayal tells investors in a research note. He thinks today's news should be viewed as a "timely delivery of a significant near-term milestone by the management team."
02/05/19
HCWC
02/05/19
NO CHANGE
Target $11
HCWC
Buy
H.C. Wainwright reiterates $11 target on Amyris after $255M cannabinoid deal
Amyris this morning announced a $255M collaboration agreement, its largest yet, with an unnamed partner, for cannabinoid development and licensing, H.C. Wainwright analyst Amit Dayal tells investors in a research note. The analyst reiterates a Buy rating on the shares with an $11 price target. The stock in morning trading is up 42%, or $1.33, to $4.49. Dayal believes the agreement calls for several molecules that will be targeting multiple products and end markets, with the first commercial production taking place in 18-24 months. He thinks the early applications are targeting opportunities in the skin care and beverage markets. Further, with an executed binding term sheet in place leading to the announcement, Dayal sees a "high probability" of the deal closing within the expected timeline. And since the non-psychoactive cannabidiol based molecules developed using Amyris' fermentation technology are likely to bypass the psychoactive tetrahydrocannabinol molecule pathway, the regulatory approval process "should not run afoul of the federal THC related restrictions," the analyst writes. He views today's announcement as an "important signal about the scalability" of Amyris' technology platform to enter large new markets very quickly. The analyst also believes the development timeline is "realistic given that product development has been accelerating at the company."

TODAY'S FREE FLY STORIES

F

Ford

$10.38

0.965 (10.26%)

10:40
04/26/19
04/26
10:40
04/26/19
10:40
Options
Heavy trading in Ford as shares see relative strength »

Heavy trading in Ford as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 03

    May

  • 09

    May

  • 24

    Jul

  • 23

    Oct

BIIB

Biogen

$229.36

-0.42 (-0.18%)

, AMGN

Amgen

$181.02

0.55 (0.30%)

10:37
04/26/19
04/26
10:37
04/26/19
10:37
Earnings
Fly Intel: What to watch in large cap biotech earnings reports »

The earnings season for…

BIIB

Biogen

$229.36

-0.42 (-0.18%)

AMGN

Amgen

$181.02

0.55 (0.30%)

CELG

Celgene

$94.00

0.07 (0.07%)

GILD

Gilead

$65.04

0.92 (1.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 28

    Apr

  • 29

    Apr

  • 30

    Apr

  • 30

    Apr

  • 01

    May

  • 02

    May

  • 03

    May

  • 04

    May

  • 06

    May

  • 08

    May

  • 18

    May

  • 21

    May

  • 29

    May

  • 31

    May

  • 27

    Jun

  • 03

    Sep

MMM

3M

$190.77

0.1 (0.05%)

10:30
04/26/19
04/26
10:30
04/26/19
10:30
Options
3M puts active Friday after a big loss in shares Thursday »

3M puts active Friday…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

  • 18

    May

  • 29

    May

LOGC

LogicBio Therapeutics

$13.20

(0.00%)

10:28
04/26/19
04/26
10:28
04/26/19
10:28
Hot Stocks
Breaking Hot Stocks news story on LogicBio Therapeutics »

LogicBio Therapeutics Inc…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

HBM

Hudbay Minerals

$6.70

0.11 (1.67%)

10:28
04/26/19
04/26
10:28
04/26/19
10:28
Hot Stocks
Glass Lewis recommends Hudbay Minerals investors vote for Waterton nominees »

Waterton Precious Metals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:25
04/26/19
04/26
10:25
04/26/19
10:25
Conference/Events
UBS alternative energy analyst to hold an analyst/industry conference call »

Alternative Energy…

SCHW

Charles Schwab

$44.93

-0.385 (-0.85%)

10:25
04/26/19
04/26
10:25
04/26/19
10:25
Conference/Events
Charles Schwab to hold a webcast »

Management holds a 2019…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 15

    May

DIS

Disney

$138.97

1.67 (1.22%)

10:24
04/26/19
04/26
10:24
04/26/19
10:24
Periodicals
Disney sees $60M in 'Endgame' sales from Thursday previews, Bloomberg reports »

Disney estimated $60M in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 08

    May

LOGC

LogicBio Therapeutics

$13.20

(0.00%)

10:23
04/26/19
04/26
10:23
04/26/19
10:23
Hot Stocks
Breaking Hot Stocks news story on LogicBio Therapeutics »

LogicBio Therapeutics Inc…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

GS

Goldman Sachs

$201.34

-0.11 (-0.05%)

10:22
04/26/19
04/26
10:22
04/26/19
10:22
Periodicals
Goldman plans to open stock brokerage in Mexico, Bloomberg says »

Goldman Sachs expects to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 02

    May

  • 07

    May

  • 29

    May

  • 03

    Jun

  • 11

    Jun

MTN

Vail Resorts

$217.80

0.5 (0.23%)

, TOCA

Tocagen

$9.55

0.42 (4.60%)

10:21
04/26/19
04/26
10:21
04/26/19
10:21
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

MTN

Vail Resorts

$217.80

0.5 (0.23%)

TOCA

Tocagen

$9.55

0.42 (4.60%)

DOW

Dow Inc.

$55.28

-0.05 (-0.09%)

GILD

Gilead

$64.80

0.68 (1.06%)

REED

Reed's

$3.94

0.06 (1.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 02

    May

  • 02

    May

  • 03

    May

  • 06

    May

  • 08

    May

  • 18

    May

  • 29

    May

SBUX

Starbucks

$75.44

-1.63 (-2.12%)

, AXTA

Axalta Coating

$26.65

-0.06 (-0.22%)

10:21
04/26/19
04/26
10:21
04/26/19
10:21
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

SBUX

Starbucks

$75.44

-1.63 (-2.12%)

AXTA

Axalta Coating

$26.65

-0.06 (-0.22%)

RACE

Ferrari

$134.74

-0.83 (-0.61%)

STX

Seagate

$44.77

-1.32 (-2.86%)

WDC

Western Digital

$49.77

-3.18 (-6.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

  • 30

    Apr

  • 01

    May

  • 07

    May

  • 06

    Jun

CLF

Cleveland-Cliffs

$9.83

0.12 (1.24%)

, ARGO

Argo Group

$75.29

1.08 (1.46%)

10:21
04/26/19
04/26
10:21
04/26/19
10:21
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

CLF

Cleveland-Cliffs

$9.83

0.12 (1.24%)

ARGO

Argo Group

$75.29

1.08 (1.46%)

ITW

Illinois Tool Works

$152.18

0.915 (0.60%)

MDCO

The Medicines Co.

$31.48

1.64 (5.50%)

ESPR

Esperion

$44.11

1.09 (2.53%)

SFLY

Shutterfly

$43.11

0.81 (1.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

  • 03

    May

  • 06

    May

  • 07

    May

  • 08

    May

  • 15

    May

  • 11

    Jun

MDLZ

Mondelez

$49.97

-0.02 (-0.04%)

10:20
04/26/19
04/26
10:20
04/26/19
10:20
Options
Mondelez puts active ahead of earnings »

Mondelez puts active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 30

    Apr

  • 15

    May

  • 29

    May

10:20
04/26/19
04/26
10:20
04/26/19
10:20
General news
The upwardly-revised April Michigan sentiment drop »

The upwardly-revised…

10:20
04/26/19
04/26
10:20
04/26/19
10:20
General news
Treasury Action: yields have extended slightly lower »

Treasury Action: yields…

WBC

Wabco

$133.12

-0.08 (-0.06%)

10:17
04/26/19
04/26
10:17
04/26/19
10:17
Downgrade
Wabco rating change  »

Wabco downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
04/26/19
04/26
10:17
04/26/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$139.40

2.1 (1.53%)

, SSNLF

Samsung

$0.00

(0.00%)

10:16
04/26/19
04/26
10:16
04/26/19
10:16
Earnings
Fly Intel: What to watch in Spotify earnings report »

Spotify (SPOT) is…

DIS

Disney

$139.40

2.1 (1.53%)

SSNLF

Samsung

$0.00

(0.00%)

SPOT

Spotify

$134.88

2.08 (1.57%)

FOX

Fox Corp.

$37.49

-0.13 (-0.35%)

CMCSA

Comcast

$43.19

0.24 (0.56%)

T

AT&T

$30.64

0.305 (1.01%)

AMZN

Amazon.com

$1,905.19

2.66 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 28

    Apr

  • 29

    Apr

  • 06

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 10

    May

  • 18

    May

  • 20

    May

  • 22

    May

  • 03

    Jun

  • 24

    Jul

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
04/26/19
04/26
10:16
04/26/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,901.49

-1.04 (-0.05%)

, UPS

UPS

$103.84

-1.29 (-1.23%)

10:11
04/26/19
04/26
10:11
04/26/19
10:11
On The Fly
Amazon 'goes for the jugular' with one-day Prime shipping »

Shares of Amazon.com…

AMZN

Amazon.com

$1,901.49

-1.04 (-0.05%)

UPS

UPS

$103.84

-1.29 (-1.23%)

WMT

Walmart

$101.87

-1.65 (-1.59%)

TGT

Target

$78.14

-3.6 (-4.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

  • 09

    May

  • 10

    May

  • 16

    May

  • 21

    May

  • 22

    May

  • 29

    May

  • 03

    Jun

  • 05

    Jun

  • 05

    Jun

  • 07

    Jun

  • 24

    Jul

  • 13

    Nov

USO

United States Oil Fund

$13.29

-0.23 (-1.70%)

10:10
04/26/19
04/26
10:10
04/26/19
10:10
Options
Size option block in US Oil Fund as shares slip »

Size option block in US…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIG

Transocean

$8.74

-0.19 (-2.13%)

10:05
04/26/19
04/26
10:05
04/26/19
10:05
Options
Transocean call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 22

    May

10:05
04/26/19
04/26
10:05
04/26/19
10:05
General news
U.S. consumer sentiment improved to 97.2 in the final April reading »

U.S. consumer sentiment…

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$291.70

-0.42 (-0.14%)

10:04
04/26/19
04/26
10:04
04/26/19
10:04
General news
Trump says trade deal with China 'going very well' »

When speaking to…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$291.70

-0.42 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.